MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 21 - per page Next page
Order by
Alzheimer's disease (AD), widely regarded as the most common cause of dementia, is a progressive neurological disorder. It can result in symptoms like memory loss, personality alterations and difficulty in communicating and performing routine tasks. More
In terms of world-wide sales, the current antidepressant of choice is the selective serotonin re-uptake inhibitor (SSRI) More
The characteristic appearance and movement of a patient with advanced Parkinson's Disease are the stooped and rigid posture, shuffling gait, tremor, and constant movement of the thumb and forefinger described as 'pill-rolling' More
Essentially, migraine is a severe pain in the head, usually one-sided, that is frequently associated with nausea and vomiting. More
A 'stroke' is a fairly innocuous term for what can be a terrifying medical emergency - perhaps the American use of 'brain attack' is more appropriate. More
"It bothers me that I asked my daughter if she would take the clothes home with her to put them in her dryer. After she left I realised that I have my own dryer that I have been using for the past three years." More
With many treatments available, the pipeline for new drugs to treat this enigmatic disease is thin. More
In 2004, Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award More
A neuroscience company focused on developing novel drugs for the treatment of CNS disorders, Amarin's lead product, MiraxionTM, is in development for Huntington's disease and treatment-unresponsive depression More
A detailed look at the different aspects of panic disorder More
Displaying 1..10 of 21 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us